{"owner": "ArrayExpress Uploader", "ownerprofile_id": "arrayexpress_sid", "id": 5167, "factors": [{"12hour_DMSO_1": {"DOSE": 0.5, "TIME": 12, "COMPOUND": "DMSO"}}, {"12hour_DMSO_1": {"DOSE": 0.5, "TIME": 12, "COMPOUND": "DMSO"}}, {"12hour_DMSO_1": {"DOSE": 0.5, "TIME": 12, "COMPOUND": "DMSO"}}, {"12hour_TCDD_1": {"DOSE": 10.0, "TIME": 12, "COMPOUND": "TCDD"}}, {"12hour_TCDD_1": {"DOSE": 10.0, "TIME": 12, "COMPOUND": "TCDD"}}, {"12hour_TCDD_1": {"DOSE": 10.0, "TIME": 12, "COMPOUND": "TCDD"}}, {"24hour_DMSO_1": {"DOSE": 0.5, "TIME": 24, "COMPOUND": "DMSO"}}, {"24hour_DMSO_1": {"DOSE": 0.5, "TIME": 24, "COMPOUND": "DMSO"}}, {"24hour_DMSO_1": {"DOSE": 0.5, "TIME": 24, "COMPOUND": "DMSO"}}, {"24hour_TCDD_1": {"DOSE": 10.0, "TIME": 24, "COMPOUND": "TCDD"}}, {"24hour_TCDD_1": {"DOSE": 10.0, "TIME": 24, "COMPOUND": "TCDD"}}, {"24hour_TCDD_1": {"DOSE": 10.0, "TIME": 24, "COMPOUND": "TCDD"}}, {"48hour_DMSO_1": {"DOSE": 0.5, "TIME": 48, "COMPOUND": "DMSO"}}, {"48hour_DMSO_1": {"DOSE": 0.5, "TIME": 48, "COMPOUND": "DMSO"}}, {"48hour_DMSO_1": {"DOSE": 0.5, "TIME": 48, "COMPOUND": "DMSO"}}, {"48hour_TCDD_1": {"DOSE": 10.0, "TIME": 48, "COMPOUND": "TCDD"}}, {"48hour_TCDD_1": {"DOSE": 10.0, "TIME": 48, "COMPOUND": "TCDD"}}, {"48hour_TCDD_1": {"DOSE": 10.0, "TIME": 48, "COMPOUND": "TCDD"}}], "pop_total": 0, "platform": 4, "summary_wrapped": "[u'The integration of different \\u201comics\\u201d technologies has already been shown in several in vivo studies to offer a complementary...", "pubmed_id": 21880148, "geo_gse_id": "E-MEXP-2817", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 3, "sample_count": 18, "tags": ["cell", "line"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_id_plat": "E-MEXP-2817_A-AFFY-44", "slug": "transcription-profiling-by-array-of-human-hepg2-2", "geo_gds_id": "", "name": "Transcription profiling by array of human HepG2 cells treated with TCDD", "created": "Sep.22, 2014", "summary": "[u'The integration of different \\u201comics\\u201d technologies has already been shown in several in vivo studies to offer a complementary insight into cellular responses of toxic processes. We therefore hypothesize that the combining of transcriptomics and metabonomics data may improve the understanding of molecular mechanisms underlying non-genotoxic carcinogenicity in vitro. To test this hypothesis, the human hepatocarcinoma cell line HepG2 was exposed to the well known environmental pollutant TCDD. ', {u'br': None}, {u'br': None}, u'A custom CDF file is available on the FTP site for this experiment (in file E-MEXP-2817.additional.zip) for use with the normalized data file for this experiment.']", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2817", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2817/samples/"}